Sat Apr 19 16:10:46 UTC 2025: ## US Warns of Chinese Biotech Domination, Urges Massive Investment
**Washington D.C.** – A new report from the U.S. National Security Commission on Emerging Biotechnology warns of a looming Chinese dominance in biotechnology, posing a significant national security threat to the United States. The Commission, after a two-year investigation, concludes that China’s strategic prioritization of biotechnology over the past two decades has resulted in market distortion and a rapid ascent to near-dominance.
The report, submitted to Congress this week, paints a stark picture, suggesting China may weaponize the technology, potentially creating AI-enhanced “super-soldiers.” It warns that unless the U.S. takes immediate action within the next three years, it risks irreversible setbacks. The Commission uses the analogy of a future “ChatGPT moment” for biotechnology, emphasizing that if China achieves a breakthrough first, the U.S. will be unable to catch up.
The report details China’s alleged tactics, mirroring its strategies in other technological sectors: stealing intellectual property, scaling production, and ultimately cornering the market to stifle competition. The recent Chinese restrictions on gallium and germanium, which disrupted U.S. semiconductor production, are cited as an example.
The report highlights China’s Military-Civil Fusion strategy, aiming to integrate biotechnology into its military to create a world-class army by 2049. This includes the potential development of genetically enhanced soldiers, making current drone warfare seem “quaint” in comparison. The Beijing Genomics Institute (BGI) and MGI Tech are cited as examples of Chinese companies with undisclosed state support, distorting the genomic sequencing market. India’s imposition of anti-dumping duties on certain Chinese active pharmaceutical ingredients (APIs) in 2022 is also noted as a response to this unfair competition.
The Commission recommends a $15 billion investment over the next five years to bolster the U.S. biotechnology sector and calls for a two-pronged approach: accelerating American innovation and slowing China’s progress. This includes protecting American intellectual property and data from Chinese state-sponsored espionage, even if it requires using more expensive alternatives. The report acknowledges India’s prioritization of cost-effective bio-manufacturing and suggests increased collaboration with allies to leverage their strengths. The report concludes with a strong warning that the window for decisive action is rapidly closing.
First Piper 